Gastroenterology clinics of North AmericaHumansBarrett EsophagusEsophageal NeoplasmsAdenocarcinomaPrecancerous Conditions
Clinical Utility of Biomarkers for Barrett's Esophagus: Guidelines and Future Directions.
Margaret J Zhou, Tarek Sawas, David A Leiman, Sachin Wani
Published: 202610.1016/j.gtc.2025.10.001
Abstract
Barrett's esophagus (BE) is a major risk factor for the development of esophageal adenocarcinoma (EAC) and is the only known precursor lesion for this lethal cancer. Although BE is relatively common among patients with gastroesophageal reflux disease…
Preview only. Read the full abstract at the source